Indian Swimming Loses an Asian Games Berth Over Terbutaline: The 18-Month Ban and the Gap Between Medicine and Paperwork

In the 200m individual medley at Asian junior meets, the gap between first place and fifth place often sits inside 1.8 seconds — less time than a referee needs to reset a stopwatch. I have a habit of rewatching those tapes, and what makes me pause has never been the scoreboard. It is the story of a 17-year-old swimmer who qualified for two events at the 2026 Asian Games in Aichi-Nagoya, Japan, yet cannot show up because of one line on a doping control form.

The Swimming Federation of India (SFI) withdrew the swimmer's name from the Commonwealth Games roster and then from the Asian Games roster. He received an 18-month suspension. An expedited hearing took place last week in the hope that a dropped case would restore his berth in Japan. The outcome went the other way.

The timeline matters. The athlete returned a positive sample in February and was subsequently removed from national team rosters. The sample tested positive for terbutaline, a beta-2 agonist commonly prescribed for asthma, emphysema, bronchitis and other lung conditions. It is familiar enough that almost any athlete who has walked into a training centre medical room has heard its name.

According to Indian media, the explanation offered was smoke inhalation and use of the medication under a doctor's approval. But he did not properly obtain a therapeutic use exemption, the TUE that permits an athlete to use a prohibited substance for legitimate medical reasons. Here is the detail I want to stress: he listed the substance on his doping control form. Someone trying to hide it does not voluntarily write a banned substance on a declaration.

The athlete's identity was not officially released because he is a minor. Domestic media pointed to one identifying detail: he has a twin brother still on the Asian Games team. Only one Indian swimmer fits that description. The two brothers have represented India at junior international meets, under similar names, to the point that results sheets sometimes merge the two and make their individual records hard to separate.

This is where I want to linger, more than on the ban itself.

In doping cases, the standard sanction is four years. That can drop to two if the panel believes the athlete did not intentionally dope, with further reductions based on how well the athlete explains the unintentional use. The actual penalty here was 18 months. In other words, the panel accepted part of the medical story, but not all of it.

When I reconstruct the sequence, what emerges is not a fraud case. It is an operational failure. A 17-year-old inhaled smoke, saw a doctor, received a prescription, took the medication, declared the medication — and still lost. He lost at the final step, the one nobody trained him for: filing the TUE before using the substance.

I once spent nearly two years working with sports medical data at club level, and I drew a fairly uncomfortable conclusion. Most athletes understand very well which substances are banned. Very few understand the administrative process surrounding those substances. Those two bodies of knowledge live in different worlds, and the Indian case is proof of the gap between them.

Inside the doping system, an administrative error and deliberate cheating can produce the same outcome — losing a competition berth — even though the two acts are fundamentally different. That is what troubles me, not the ban itself.

There is a reason this story deserves to be read at system level rather than only at individual level. India is the world's most populous country but not a global sporting superpower. At the 2026 Olympics, the entire delegation won six medals and no golds. Meanwhile, India has consistently led the world in anti-doping violations for years.

Those two facts, placed side by side, tell a story few want to hear. In a country with limited resources, where specialised sports medicine does not reach everywhere, doping violations often do not come from a sophisticated cheating network. They come from a shortage of team doctors, compliance officers and someone sitting beside the athlete to process a TUE before things slip out of reach.

In other words, India does not lead the world in doping because its athletes cheat more than others. It leads partly because they are less protected from the administrative traps — like the one that blocked a 17-year-old swimmer from the Asian Games.

I once published a small analytical framework on how different federations handled TUEs after the Tokyo Olympics, and one thing stood out clearly: most sanctioned cases, read closely, share a common thread — the athlete did not know what to do next. They knew what they took. They did not know where to declare it, when, or on which form.

That is the kind of mistake data can catch before it happens, if someone sits down to look. Data does not judge, but it points me to the questions others forget.

Now the most overlooked part: the twin brother.

The two brothers have similar names. In junior international results, their records have been mixed up several times. Now one is preparing to travel to the Asian Games and the other is serving a ban. Media had to use indirect descriptions — a 17-year-old swimmer whose twin remains on the team — just to refer to someone who could not be named without dragging the other along.

If this had happened in a country that regularly draws international attention, the media would have sharp enough identification tools to pin down the sanctioned athlete. But in a country where junior meets get little coverage and databases are fuzzy enough to merge two people into one, an administrative error does not just close a competition berth. It opens the possibility of attributing fault to an innocent party.

This is where I see Asian federations' athlete data handling lagging behind their population scale. Similar names, same national representation, same age group — a serious record system must distinguish two human beings by more than a string of characters.

I once misread a player's name at a World Cup, and rebuilt my entire way of watching matches from that. I know the feeling: knowing that the smallest confusion between two people can skew an entire record. In this case the confusion did not happen on the fan side. It risks happening on the official file side.

Across the sea, I see a different handling. Major European federations usually separate the roles: a team doctor handles the TUE, an independent officer reviews each athlete's banned-substance list quarterly, and there is a contingency process for unplanned emergencies. Those three layers of protection do not make an athlete swim easier. They only ensure a medical experience does not become an administrative sentence.

In India, the problem is that these three layers often collapse into one person, or do not formally exist. When everything falls on a 17-year-old, he must remember training schedules, medication schedules and the obligation to file an exemption. If just one of those three slips from his mind, a sanction appears.

Here I have to be careful. The conventional explanation is that athletes must take responsibility for what they put in their bodies. That argument has its own logic, and I respect it. No one else took the medication for him. Personal responsibility is a founding principle of the entire anti-doping system, and if you erase it, the system collapses within one season.

But I want to push that logic one step further, to the point where it turns counterintuitive. If responsibility rested entirely with athletes, then well-resourced federations would never have violations, because their athletes would be fully equipped to be responsible. Reality is the opposite: many wealthy nations still violate regularly; they just have better lawyers to reduce the penalty. The difference is not awareness. It is the ability to buy compliance services.

And that, I think, is what the 18-month ban inadvertently reveals: the system processes paperwork, not intent. The panel partly believed the medical story — otherwise the number would be four years. But they still issued a sanction. The final outcome for the athlete is the same whether he was intentional or unintentional: no swimming at the Asian Games.

An injury is where every analytical model must bow — and also where I have learned the most. A paperwork error carries similar force, except it does not hurt physically. It is quieter, and therefore less visible in the news.

For this 17-year-old, 18 months is a strangely long stretch. He is still growing, can still return, but missing one Asian Games cycle means missing exactly the window in which a young swimmer accumulates international experience. In swimming, the years from 17 to 19 often decide whether an athlete rises to continental level or stops at national level.

There are discoveries that do not come from luck, but from being willing to read the movements the crowd overlooks. Here, the overlooked movement is not underwater. It is on a form.

I do not know whether he will come back. I do not know whether the Swimming Federation of India will change its process after this case. But I know one thing I want youth federations across Asia to ask themselves: if tomorrow a 17-year-old walks into a medical room with an asthma attack, does he know exactly what to do next — or will he learn it from a doping control form, after everything is already too late?